Filter by tags: Radiopharmaceutical CANDU reactor Clear all tag filters
2 news articles found
Lutetium-177 (Lu-177) has been produced using a new isotope production system (IPS) that was installed in unit 7 of the Bruce plant in Ontario, Canada, during a recent planned maintenance outage. It marks the first time the short-lived medical isotope has been produced in a commercial nuclear power reactor.
- Source: World Nuclear News
- Date: Thursday, 23 June 2022
- Original article: world-nuclear-news.org/Articles/Canadian-Candu-produces-cancer-therapy-isotope
Three recent announcements will help secure future supplies of vital medical radioisotopes. Westinghouse Electric Company and Nordion (Canada) Inc are to work together on technology to produce cobalt-60 in pressurised water reactors (PWRs); Framatome and Kinectrics have launched a new joint venture to produce lutetium-177 in partnership with Bruce Power; and BWXT Technologies' proprietary technetium-99m generators have passed a testing milestone.
- Source: World Nuclear News
- Date: Saturday, 29 February 2020
- Original article: world-nuclear-news.org/Articles/Companies-work-on-securing-medical-isotope-supplie